Search for: "Eli Lilly "
Results 1081 - 1100
of 2,131
Sorted by Relevance
|
Sort by Date
23 Sep 2013, 10:00 am
., Dolby Laboratories, The Dow Chemical Company, DuPont, Eli Lilly & Company, General Electric, IBM, Innovation Alliance, Inventors Network of the Capital Area, Johnson & Johnson, Microsoft, National Association of Manufacturers (NAM), Procter & Gamble, Qualcomm, Tessera, U.S. [read post]
3 Apr 2017, 7:03 am
Here are our leading legal headlines for the week of April 3, 2017 from Wise Law on Twitter: Eli Lilly loses NAFTA challenge brought against CanadaHow one province is tackling racial profiling in storesEqual Pay for Men and Women? [read post]
5 Jan 2022, 6:40 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
18 Dec 2013, 2:32 am
An FDA spokesman told The Times that so far, the agency has received commitments to follow the plan from two major drug producers, former Pfizer subsidiary Zoetis and Elanco, which is owned by Eli Lilly & Co. [read post]
11 Jun 2019, 1:19 am
The patent was exclusively licenced to Eli Lilly. [read post]
13 Nov 2012, 4:40 pm
(Eli Lilly & Co., which marketed the diabetes drug for Takeda in the US, is also a common defendant.) [read post]
7 Aug 2018, 10:05 pm
Prior to this change, advice provided by foreign practitioners was not protected by patent attorney privilege (Eli Lilly & Company v Pfizer Ireland Pharmaceuticals (No 2) [2004] FCA 850: ‘The language of s 200(2) is clear. [read post]
16 Sep 2017, 9:46 am
Eli Lilly & Co., 119 F.3d 1559, 1575 (Fed. [read post]
25 Jul 2013, 10:14 am
Eli Lilly and Co., 598 F.3d 1336, 1351 (Fed. [read post]
23 Jun 2015, 2:54 am
In re Eli Lilly and Company, Serial No. 85183667 (June 18, 2015) [not precedential].The examining attorney maintained that the specimen of use (shown below) "shows the proposed mark as part of [a] logically connected and continuous sentence .... [read post]
9 Sep 2015, 10:03 am
IP Tango, the bilingual Latin American blog, hosts an account by Magda Voltolini of a spot of sham litigation in Brazil on the part of pharma giant Eli Lilly. [read post]
4 May 2013, 10:13 am
Tradjenta (linagliptin) is manufactured by Eli Lilly and Boehringer Ingelheim and approved for sale in 2011. [read post]
28 Jul 2023, 8:26 am
However, it follows a similar action filed in May by Lake County, Illinois in which the County accuses Eli Lilly, Novo Nordisk, Sanofi, Express Scripts, and OptumRx are accused of violating the state's Consumer Fraud Act and the RICO Act. [read post]
11 Jun 2019, 1:19 am
The patent was exclusively licenced to Eli Lilly. [read post]
16 Jan 2013, 3:41 pm
Planned Parenthood National Blood Clot Alliance Women's Health Birth Control Guide, Food and Drug Administration More Blog Posts:DES Lawsuit Against Eli Lilly is Resolved with Settlement, Drug Injury Lawyers Blog, January 11, 2013 Boston Dangerous Drug Lawsuits: YAZ, Ocella, and Yasmin Birth Control Pills Linked to Deep Vein Thrombosis, Pulmonary Embolism, Stroke, Heart Attack, and Myocardial Infarction Side Effects, Boston Injury Lawyer Blog, June 19, 2012 Plaintiff of… [read post]
26 Mar 2017, 1:49 am
The first such substance to be approved for therapeutic use was synthetic ‘human’ insulin, developed by Genentech and first marketed by Ely Lilly in 1982. [read post]
27 Nov 2021, 2:12 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
25 Feb 2015, 8:03 am
Opening Address: Professor Emily Michiko Morris, IU McKinney School of Law, The Changing Landscape in Biopharmaceuticals 9:00 - 10:15 Panel One: University Tech Transfers in BioPharma Chad Pittman, Vice President, Purdue Research Foundation James Myers, JD, PhD, Eli Lilly Professor Greg Dolin, University of Baltimore School of Law Moderator: Constance Lindman, Partner, SmithAmundsen 10:30 - 11:45 Panel Two: Legal Issues in Clinical Trials (US and Asia) Professor Rebecca S. [read post]
5 Jun 2019, 6:45 am
Karuna, whose founders worked at Eli Lilly and Takeda Pharmaceuticals, makes medicines to address neuropsychiatric conditions. [read post]
12 Dec 2013, 7:12 am
In short, where the patent holder has already obtained an SPC on the basis of a patent protecting an innovative active ingredient and a marketing authorisation for a medicinal product containing that ingredient as the single active ingredient, and that SPC entitles him to oppose the use of that active ingredient, either alone or in combination with other active ingredients, Article 3(c) of the SPC Regulation must be interpreted as precluding that patent holder from obtaining –- on the basis of… [read post]
